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Background: Dental disease is more extensive in adults with chronic kidney disease, but whether dental
health and behaviors are associated with survival in the setting of hemodialysis is unknown.
Study Design: Prospective multinational cohort.
Setting & Participants: 4,205 adults treated with long-term hemodialysis, 2010 to 2012 (Oral Diseases in
Hemodialysis [ORAL-D] Study).
Predictors: Dental health as assessed by a standardized dental examination using World Health Organi-
zation guidelines and personal oral care, including edentulousness; decayed, missing, and filled teeth index;
teeth brushing and flossing; and dental health consultation.
Outcomes: All-cause and cardiovascular mortality at 12 months after dental assessment.
Measurements:Multivariable-adjusted Cox proportional hazards regression models fitted with shared frailty
to account for clustering of mortality risk within countries.
Results: During a mean follow-up of 22.1 months, 942 deaths occurred, including 477 cardiovascular
deaths. Edentulousness (adjusted HR, 1.29; 95% CI, 1.10-1.51) and decayed, missing, or filled teeth
score $ 14 (adjusted HR, 1.70; 95% CI, 1.33-2.17) were associated with early all-cause mortality, while
dental flossing, using mouthwash, brushing teeth daily, spending at least 2 minutes on oral hygiene daily,
changing a toothbrush at least every 3 months, and visiting a dentist within the past 6 months (adjusted
HRs of 0.52 [95% CI, 0.32-0.85], 0.79 [95% CI, 0.64-0.97], 0.76 [95% CI, 0.58-0.99], 0.84 [95% CI, 0.71-
0.99], 0.79 [95% CI, 0.65-0.95], and 0.79 [95% CI, 0.65-0.96], respectively) were associated with better
survival. Results for cardiovascular mortality were similar.
Limitations: Convenience sample of clinics.
Conclusions: In adults treated with hemodialysis, poorer dental health was associated with early death,
whereas preventive dental health practices were associated with longer survival.
Am J Kidney Dis. 66(4):666-676. ª 2015 The Authors. Published by Elsevier Inc. on behalf of the National
Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Dental Disease and Survival in HemodialysisChronic kidney disease (CKD) is responsible forapproximately 12 billion years of life lost to
premature mortality or lived with disability each
year.1 Patients with end-stage kidney disease treated
with dialysis have a particularly heavy burden of se-
vere symptoms2 and can expect to live for only 4 to 5
years on average.3,4 Despite decades of research, no
treatment strategies have been shown to improve
critical health outcomes, such as mortality, in people
with end-stage kidney disease.
Oral health represents a potential determinant of
health outcomes in people with end-stage kidney
disease. Dental conditions such as caries, tooth loss,
and poor oral hygiene are nearly universal worldwide,
particularly affecting disadvantaged populations,5,6
and are associated with excess mortality, including
cardiovascular and cancer-related deaths.7-9 Adults
who have CKD have more severe oral disease than
the general adult population,10 yet infrequently use
dental services.11 Oral disease is associated with
inﬂammation and malnutrition, which may accelerate
cardiovascular disease in the setting of dialysis treat-
ment, and therefore represents a putative etiology
for cardiovascular events in the context of kidney
failure.12,13
To our knowledge, the Oral Diseases in Hemodi-
alysis (ORAL-D) Study14 is the ﬁrst cohort study to
investigate whether oral disease using standardized
assessments of dental disease and preventative dental
health practices are associated with early death inde-
pendent of existing cardiovascular disease and other
sociodemographic factors.
METHODS
Study Population and Data Source
The ORAL-D Study included consecutive adults 18 years or
older who had been treated with long-term hemodialysis within a
convenience sample of clinics operated by a single dialysis pro-
vider in Europe (France, Hungary, Italy, Poland, Portugal, and
Spain) and South America (Argentina).14 We enrolled participants
from July 2010 to February 2012. Patients were not enrolled if
they had cognitive impairment sufﬁcient to preclude consent or
they preferred not to participate.
Demographic, clinical, laboratory, and dialysis-related data
were obtained from linked databases using a unique identiﬁcation
code. All participants underwent a standardized oral examination
by a dentist trained in periodontology, according to World Health
Organization (WHO) guidelines.15 All dentists participated in a
teleconference to calibrate the protocol before examining patients.
All participants anonymously completed questionnaires about self-
reported dental care practices.16 The exposures in analyses were
edentulousness (complete absence of teeth), extent of dental dis-
ease (decayed, missing, or ﬁlled teeth), brushing teeth, dental
ﬂossing, use of mouthwash, frequency of changing toothbrush,
time spent each day on oral hygiene, age of ﬁrst visit to a dental
practitioner, and time elapsed since the most recent dental visit.
Data for total and cause-speciﬁc mortality were obtained from
a centralized database in which changes to patient status
were updated by managing clinicians on a monthly basis. Car-
diovascular death was adjudicated by participants’ treatingAm J Kidney Dis. 2015;66(4):666-676clinicians, who were unaware of dental exposures. Deaths were
classiﬁed as due to cardiovascular causes when they were a sudden
death or death attributed to acute myocardial infarction, pericar-
ditis, atherosclerotic heart disease, cardiomyopathy, cardiac
arrhythmia, cardiac arrest, valvular heart disease, pulmonary
edema, congestive cardiac failure, or cerebrovascular accident,
including intracranial hemorrhage, ischemic brain damage
including anoxic encephalopathy, or mesenteric infarction or
ischemia of the bowel. The primary outcome deﬁned a priori was
all-cause mortality and the secondary outcome was death due to
cardiovascular causes. Patients who withdrew from the study,
underwent kidney transplantation, were lost to follow-up, or sur-
vived were censored.
Ethics Approval
We received ethics approval for the ORAL-D Study from the
following responsible local human research ethics committees:
Comitè de Protection des Personnes Sud-Medierranèe II (France),
Komisja Bioetyczna, Slaskiego Uniwersytetu Medycznego W
Katowicach (Poland), CE da Diaverum Portugal (Portugal),
Comite Etico de Investigacion Clinica (CEIC) de la Fundaction
Puigvert and Agencia Valenciana de Salud, Departament de Salut
Valencia (Spain), and Szegedi Tudomanyegyetem, Szent-Gyorgyi
albert klinikai kozpont, and Regionalis human orvosbiologiai
kutatasetikai bizottsaga (Hungary). Ethics approval was not
required in Italy or Argentina. The study was performed in
accordance with the Declaration of Helsinki.
Statistical Analysis
All statistical analyses were performed using SAS, version 9.3
(SAS Institute Inc). P , 0.05 was considered statistically
signiﬁcant.
Dental disease characteristics and health care practices were
considered as time-ﬁxed binary variables throughout the follow-up
period. In all participants, we did analyses for extent of edentu-
lousness and the decayed, missing, or ﬁlled teeth index; in dentate
participants, we did analyses for brushing teeth, using mouthwash
or dental ﬂoss, frequency of changing a toothbrush, time spent on
oral hygiene, age of starting dental care, and time elapsed since
last dental checkup. We also considered analyses for the number
of decayed, missing, or ﬁlled teeth as a categorical variable ac-
cording to the WHO classiﬁcation and as a continuous exposure
variable. In survival analyses, we included participants who had
complete data for all oral health exposure variables (n 5 4,054
participants overall, including n 5 3,243 dentate participants).
Event rates for study outcomes were calculated for each dental
exposure category, reporting Kaplan-Meier estimates. Time-to-
event cumulative incidence Kaplan-Meier curves were plotted
across dental exposure variables. Because there was heterogeneity
in risks of survival (all-cause and cardiovascular mortality) among
countries (P , 0.001), we then applied random-effects Cox pro-
portional hazard models ﬁtted using shared frailty to account for
within-country clustering of mortality risk to estimate associations
among dental status, oral hygiene and dental care variables, and
risk of early all-cause and cardiovascular mortality. We used a
lognormal distribution in the frailty model. In multivariable-
adjusted models, we controlled for the following baseline fac-
tors: age, sex, race, smoking history, self-reported family income,
prior myocardial infarction, diabetes, dialysis vintage, and mean
arterial blood pressure, hemoglobin, and serum phosphorus values.
The proportional hazards assumption in all Cox models was
assessed by ﬁtting log (time)-dependent covariates in the multi-
variable model and checking graphically by plotting Schoenfeld
residuals, but no variable violated the proportionality assumption.
We did not impute missing data.
In sensitivity analyses, we considered competing risks for death
attributable to cardiovascular causes from other causes of death.667
Table 1. Demographic, Socioeconomic, Clinical, and Dialysis Characteristics of Participants
Overall
(N 5 4,205)
Dentate
(n 5 3,338)
Edentulous
(n 5 867)
Demographics
Age, y 61.6 6 15.6 59.1 6 15.8 71.1 6 10.7
Country
Italy 593 (14.1) 409 (12.3) 184 (21.2)
Spain 189 (4.5) 122 (3.7) 67 (7.7)
France 48 (1.1) 39 (1.2) 9 (1.0)
Portugal 762 (18.1) 633 (19.0) 129 (14.9)
Poland 319 (7.6) 239 (7.2) 80 (9.2)
Hungary 550 (13.1) 415 (12.4) 135 (15.6)
Argentina 1,744 (41.5) 1,481 (44.4) 263 (30.3)
Male sex 2,426 (57.7) 1,968 (59.0) 458 (52.8)
European 3,987 (94.8) 3,145 (94.6) 842 (97.1)
Ever smoker 1,029 (33.4) 789 (32.9) 240 (35.3)
Socioeconomic characteristics
Married 2,161 (55.0) 1,694 (54.0) 467 (58.8)
Secondary education 1,139 (38.1) 926 (39.9) 213 (32.1)
Employed 387 (12.8) 366 (15.5) 21 (3.1)
Family income . domestic average 313 (8.0) 238 (7.7) 75 (9.2)
Comorbid conditions at baseline
Myocardial infarction 348 (12.5) 250 (11.6) 98 (16.1)
Stroke 287 (10.3) 213 (9.8) 74 (12.2)
Diabetes mellitus 933 (32.0) 673 (29.9) 260 (39.5)
Laboratory variables
Serum albumin, g/L 3.86 0.4 3.86 0.4 3.8 6 0.4
Serum phosphorus, mg/dL 4.66 1.5 4.76 1.5 4.3 6 1.3
Serum calcium, mg/dL 8.86 0.8 8.76 0.8 8.8 6 0.8
Hemoglobin, g/dL 11.1 6 1.3 11.1 6 1.4 11.26 1.3
Dialysis variables
Dialysis vintage, mo 60 [38-98] 62 [39-100] 56 [36-90]
Kt/Va 1.76 0.3 1.76 0.3 1.7 6 0.3
Urea reduction ratio 0.86 0.06 0.86 0.06 0.86 0.06
Mean arterial pressure, mm Hg 90.0 6 13.5 90.2 6 13.7 89.3 6 12.9
Note: Values for categorical variables are given as number (percentage); values for continuous variables are given as mean 6
standard deviation or median [interquartile range]. Conversion factors for units: calcium in mg/dL to mmol/L, 30.2495; phosphorus in
mg/dL to mmol/L,30.3229. Proportions do not always correspond to overall numbers of participants due to missing data. Missing data,
with number of participants with missing data (percentage) for each reported variable: age, 0 (0%); sex, 0 (0%); country, 0 (0%); race,
0 (0%); smoking history, overall, 1,129 (26.8%), dentate, 941 (28.2%), edentulous, 188 (21.7%); marital status, overall, 273 (6.5%),
dentate, 199 (6.0%), edentulous, 74 (8.5%); education, overall, 1,218 (29.0%), dentate, 1,015 (30.4%), edentulous, 203 (23.4%);
employment, overall, 1,178 (28.0%), dentate, 981 (29.4%), edentulous, 197 (22.7%); income, overall, 304 (7.2%), dentate, 256 (7.7%),
edentulous, 48 (5.5%); myocardial infarction, overall, 1,435 (34.1%), dentate, 1,175 (35.2%), edentulous, 260 (30.0%); stroke, overall,
1,435 (34.1%), dentate, 1,175 (35.2%), edentulous, 260 (30.0%); diabetes, overall, 1,293 (30.8%), dentate, 1,085 (32.5%), edentu-
lous, 208 (24.0%); serum albumin, overall, 896 (21.3%), dentate, 697 (20.9%), edentulous, 199 (23.0%); serum phosphorus, overall,
450 (10.7%), dentate, 359 (10.8%), edentulous, 91 (10.5%); serum calcium, overall, 444 (10.6%), dentate, 354 (10.6%), edentulous,
90 (10.4%); hemoglobin, overall, 446 (10.6%), dentate, 357 (10.7%), edentulous, 89 (10.3%); dialysis vintage, 0 (0%); Kt/V, overall,
498 (11.8%), dentate, 405 (12.1%), edentulous, 93 (10.7%); urea reduction ratio, overall, 498 (11.8%), dentate, 405 (12.1%), eden-
tulous, 93 (10.7%); mean arterial pressure, overall, 423 (10.1%), dentate, 339 (10.2%), edentulous, 84 (9.7%).
aKt/V refers to clearance of urea and is a measure of amount of dialysis received.
Palmer et alWe considered the event of interest (cardiovascular death) and
other competing events (such as death related to infection) as
events and then calculated the Kaplan-Meier estimate of overall
events. To assess the effect of including edentulous patients in
the survival analyses for the extent of decayed, missing, or ﬁlled
teeth, we additionally performed analyses excluding edentulous
patients. Finally, we included ﬁrst-order interaction terms with
combinations of all independent predictors introduced into the
multivariable model one at a time to assess heterogeneity of as-
sociations across different population subgroups.668RESULTS
Participant Characteristics
Of 4,726 patients eligible in the dialysis network,
521 (11.0%) were subsequently excluded because they
did not receive the dental component of their oral
examination (n5 113) or lacked data for centralized
registry linkages (n5 408), leaving 4,205 participants
in the analyses. Information about demographic,Am J Kidney Dis. 2015;66(4):666-676
Table 2. Baseline Dental Characteristics, Oral Hygiene Habits,
and Dental Care Practices
Parameter Value
Dental health in all, N 5 4,205
Edentulous 867 (20.6)
No. of teeth 16.8 6 9.0
Decayed, missing, filled teeth indexa 19.3 6 8.6
Decayed, missing, or filled teeth
index $ 14a
3,234 (77.5)
Oral hygiene practices in dentate patients
Use of dental floss 268/3,283 (8.2)
Use of mouthwash 1,216/3,282 (37.0)
Brushing teeth daily 3,002/3,281 (91.5)
Oral hygiene $2 min daily 2,036/3,268 (62.3)
Change toothbrush every 3 mo or less 1,222/3,259 (37.5)
Dental care practices in dentate patients
Age of first dental visit , 30 y 2,024/3,277 (61.8)
Time elapsed since last dental visit
, 6 mo
983/3,284 (29.9)
Note: Values are given as number (percentage), mean 6
standard deviation, or no. of participants with exposure/total no.
of participants included in analyses (percentage).
aThe decayed, missing, and filled teeth index is categorized
according to World Health Organization criteria as very low, ,5;
low, 5-8.9; moderate, 9-13.9; and high, $14.
Dental Disease and Survival in Hemodialysisclinical, and oral health characteristics for participants
excluded from the analyses are provided in Tables S1
and S2 (available as online supplementary material).
Table 1 displays baseline characteristics of included
participants according to the presence or complete
absence of teeth (edentulousness), and dental charac-
teristics and care practices are shown in Table 2. Mean
age of the cohort was 626 16 (standard deviation)
years, and 58% of participants were men.
Dental Characteristics of Study Participants
Overall, 867 (20.6%) participants were edentulous.
Edentulous patients were older, were more often fe-
male, had lower levels of education and employment,
and more frequently had cardiovascular comorbid
conditions. Dentate patients had 16.8 teeth on
average, with more than two-thirds demonstrating
extensive dental disease (14 or more decayed,
missing, or ﬁlled teeth). Fewer than 10% used dental
ﬂoss, about one-third used mouthwash, most brushed
their teeth at least daily, about one-third changed their
toothbrush at least every 3 months, and approximately
two-thirds spent 2 minutes or more daily on oral
hygiene. Most had visited a dentist before the age of
30 years and about one-third had consulted a dental
practitioner within the previous 6 months.
Association of Dental Health and Behaviors With
Survival
Mean follow-up was 22.1 (range, 1.3-36.2)
months. In total, there were 942 deaths, includingAm J Kidney Dis. 2015;66(4):666-676477 cardiovascular deaths, during 7,737 person-
years of follow-up (overall mortality rate, 122/
1,000 person-years). Figures 1 and 2 show survival
curves for each dental characteristic during the
course of follow-up. The proportion of patients
who died was higher with edentulousness and
dental disease. In addition, fewer patients who had
more frequent oral hygiene care and dental practi-
tioner consultation died. The estimated proportion
of participants who died (total and cardiovascular-
related mortality) at 1, 2, and 3 years of follow-
up according to the presence of oral disease or
oral health practice is shown in Table 3. The pro-
portion of patients who died was similar regardless
of age at ﬁrst dental consultation.
Table 4 shows adjusted hazard ratios (HRs) for
mortality by dental health measures. In adjusted an-
alyses, edentulousness (adjusted HR, 1.29; 95%
conﬁdence interval [CI], 1.10-1.51) and extensive
dental disease ($14 decayed, missing, or ﬁlled teeth:
HR, 1.70; 95% CI, 1.33-2.17) were associated with
increased mortality, while dental ﬂossing, using
mouthwash, brushing teeth daily, spending 2 minutes
or more on oral hygiene, changing a toothbrush at
least every 3 months, and visiting a dentist within the
past 6 months were all associated with longer survival
(adjusted HRs of 0.52 [95% CI, 0.32-0.85], 0.79
[95% CI, 0.64-0.97], 0.76 [95% CI, 0.58-0.99], 0.84
[95% CI, 0.71-0.99], 0.79 [95% CI, 0.65-0.95], and
0.79 [95% CI, 0.65-0.96], respectively). Similar re-
sults were obtained for associations with cardiovas-
cular death, except for brushing teeth daily, which
was not associated with lesser hazard of cardiovas-
cular death. The age at which patients had ﬁrst con-
sulted a dental practitioner was not associated with
either all-cause or cardiovascular mortality.
The decayed, missing, or ﬁlled teeth index showed
a dose-response relationship with all-cause and car-
diovascular mortality (Fig 3). For participants who
had 1 or more teeth, there was a linear association
between the number of decayed, missing, or ﬁlled
teeth at baseline and risk of death. The adjusted
mortality risk increased by 2.8% for each additional
decayed, missing, or ﬁlled tooth (95% CI, 1.7%-
4.0%), and the adjusted cardiovascular risk increased
by 3.3% (95% CI, 1.7%-5.0%).
Sensitivity Analyses
Similar results were found for the association be-
tween dental disease and mortality when analyses
were restricted to dentate patients only. In dentate
patients, having 14 or more decayed, missing, or ﬁlled
teeth was associated with increased adjusted risks
of all-cause mortality (HR, 1.54; 95% CI, 1.22-1.95)
and cardiovascular mortality (HR, 1.64; 95%
CI, 1.16-2.33). Analyses for the association of the669
Figure 1. Cumulative incidence of all-cause mortality for each dental health measure. The decayed, missing, and filled teeth index
(DMFT) is dichotomized according to World Health Organization criteria as very low to moderate, ,14, and high, $14.27 All 4,205 par-
ticipants were included in the survival analyses for edentulousness and the DMFT and 3,338 dentate participants were included in sur-
vival analyses for oral hygiene and dental care practices.
670 Am J Kidney Dis. 2015;66(4):666-676
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Figure 2. Cumulative incidence of cardiovascular mortality for each dental health measure. The decayed, missing, and filled teeth
index (DMFT) is dichotomized according to World Health Organization criteria as very low to moderate, ,14, and high, $14.27 All
4,205 participants were included in the survival analyses for edentulousness and the DMFT and 3,338 dentate participants were
included in survival analyses for oral hygiene and dental care practices.
Am J Kidney Dis. 2015;66(4):666-676 671
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Table 3. Kaplan-Meier Estimates for Total and Cardiovascular Mortality After 1, 2, and 3 Years of Follow-up, Stratified by Oral Disease
or Health Practice
1 Year 2 Years 3 Years
Exposure No Exposure Exposure No Exposure Exposure No Exposure
All-cause mortality
Edentulousness 15.6 (13.2-18.3) 9.8 (8.8-10.8) 30.7 (27.5-34.2) 19.1 (17.8-20.7) 40.9 (36.9-45.3) 25.4 (23.3-27.6)
Decayed, missing,
filled teeth index
12.4 (11.3-13.6) 5.9 (4.5-7.7) 24.8 (23.3-26.5) 10.3 (8.3-12.6) 33.1 (30.9-35.4) 12.8 (10.1-16.1)
Use of dental floss 4.5 (2.5-7.9) 10.2 (9.1-11.3) 8.5 (5.4-13.0) 20.0 (18.5-21.6) 8.5 (5.4-13.0) 26.7 (24.5-29.1)
Use of mouthwash 7.5 (6.1-9.1) 11.0 (9.7-12.5) 15.1 (13.0-17.4) 21.5 (20.0-23.5) 22.1 (18.7-26.0) 27.4 (24.9-30.2)
Brushing teeth daily 9.3 (8.3-10.4) 14.2 (10.4-19.2) 18.5 (17.0-20.0) 26.1 (20.9-32.4) 24.8 (22.6-27.1) 32.8 (26.4-40.2)
Oral hygiene $2 min
daily
8.9 (7.7-10.2) 11.1 (9.4-13.0) 17.1 (15.4-19.0) 22.2 (19.9-24.9) 22.9 (20.5-25.5) 29.3 (25.7-33.4)
Change toothbrush
every 3 mo or less
6.6 (5.3-8.2) 11.5 (10.2-13.0) 15.3 (13.2-17.6) 21.3 (19.5-23.3) 20.1 (17.4-23.3) 28.3 (25.6-31.3)
Age of first dental visit
, 30 y
9.0 (7.6-10.7) 10.2 (8.9-11.7) 18.2 (16.1-20.4) 19.8 (17.9-21.8) 25.4 (22.1-29.1) 25.1 (22.7-27.8)
Last dental visit within
6 mo
7.7 (6.1-9.6) 10.6 (9.3-11.9) 14.5 (12.3-17.1) 21.0 (19.3-22.8) 19.8 (16.7-23.4) 27.8 (25.2-30.7)
Cardiovascular mortality
Edentulousness 8.2 (6.5-10.4) 5.3 (4.5-6.1) 17.1 (14.5-20.2) 10.1 (9.0-11.3) 24.4 (20.5-28.3) 13.6 (12.0-15.5)
Decayed, missing,
filled teeth index
6.8 (5.9-7.7) 2.9 (2.0-4.3) 13.4 (12.2-14.8) 5.1 (3.8-7.0) 18.8 (16.9-20.8) 5.4 (4.0-7.3)
Use of dental floss 1.3 (0.4-3.9) 5.6 (4.8-6.5) 2.3 (1.0-5.5) 10.7 (9.6-12.0) 2.3 (1.0-5.5) 14.6 (12.9-16.6)
Use of mouthwash 3.3 (2.4-4.5) 6.4 (5.4-7.6) 6.8 (5.4-8.6) 12.0 (10.6-13.7) 10.2 (7.5-13.8) 15.9 (13.8-18.1)
Brushing teeth daily 5.2 (4.4-6.1) 6.4 (3.9-10.5) 9.7 (8.6-11.0) 14.1 (10.0-19.6) 13.0 (11.3-15.0) 20.8 (15.1-28.3)
Oral hygiene $2 min
daily
4.7 (3.8-5.8) 6.2 (5.0-7.8) 8.6 (7.4-10.1) 12.4 (10.6-14.6) 11.6 (9.8-13.8) 16.9 (14.0-20.3)
Change toothbrush
every 3 mo or less
3.8 (2.8-5.1) 6.2 (5.2-7.3) 8.2 (6.6-10.1) 11.2 (9.8-12.8) 10.2 (8.2-12.7) 15.6 (13.4-18.2)
Age of first dental visit
, 30 y
4.5 (3.5-5.8) 5.9 (4.8-7.1) 10.2 (8.6-12.1) 10.0 (8.6-11.5) 14.5 (12.0-17.5) 12.9 (10.9-15.2)
Last dental visit within
6 mo
4.4 (3.3-6.0) 5.7 (4.8-6.7) 7.4 (5.8-9.5) 11.2 (9.9-12.7) 10.7 (8.1-14.0) 14.9 (12.9-17.2)
Note: Values are percentages and are given as estimate (95% confidence interval).
Palmer et aldecayed, missing, and ﬁlled teeth index with cardio-
vascular mortality when considering competing risks
from other causes of death showed similar results,
with an adjusted incidence of death of 21.0% in pa-
tients with a decayed, missing, and ﬁlled teeth index
score $ 14 compared with 12.2% in those with fewer
decayed, missing, or ﬁlled teeth (adjusted HR, 1.75).
The only signiﬁcant interaction term was age.
Adjusted associations of edentulousness with all-cause
mortality (P for interaction 5 0.001) and cardiovas-
cular mortality (P for interaction , 0.001) were
stronger in adults younger than 60 years (HRs of 1.74
[95% CI, 1.15-2.62] and 2.48 [95% CI, 1.47-4.17])
than for older adults (HRs of 1.33 [95% CI, 1.15-1.55]
and 1.29 [95% CI, 1.05-1.60]). Similarly, associations
of the decayed, missing, and ﬁlled teeth index with all-
cause mortality (P for interaction 5 0.04) and car-
diovascular mortality (P for interaction 5 0.07) were
somewhat stronger in adults younger than 60 years
(HRs of 2.50 [95% CI, 1.71-3.64] and 2.82 [95% CI,
1.56-5.10]) than for older adults (HRs of 1.56 [95%
CI, 1.18-2.05] and 1.58 [95% CI, 1.07-2.33]).672DISCUSSION
This study suggests that dental health status and
behaviors inﬂuence the risk of death in people
treated with hemodialysis independent of other risk
factors, including income and comorbid conditions.
Tooth loss and extensive dental disease were
associated with increased risks of all-cause and
cardiovascular mortality, and the extent of decayed,
missing, or ﬁlled teeth showed a dose-response
relationship with early mortality. Dental care be-
haviors, particularly the use of dental ﬂoss or
mouthwash, but also daily teeth brushing, spending
time on oral hygiene each day, more frequent
dental visits, and changing a toothbrush more
often, were associated with better survival. Dental
disease at a younger age appeared more strongly
linked to mortality outcomes. These associations
between survival and dental health were observed
across several countries in Europe and Argentina
and were independent of measured sociodemo-
graphic and clinical factors.Am J Kidney Dis. 2015;66(4):666-676
Table 4. Dental Health, Oral Hygiene Habits, and Dental
Care Practice Variables Associated With All-Cause and
Cardiovascular Mortality in Adults With End-Stage
Kidney Disease
Death From
Any Cause
Death From
Cardiovascular
Event
Edentulousness 1.29 (1.10-1.51) 1.28 (1.02-1.60)
Decayed, missing, filled
teeth index $ 14a
1.70 (1.33-2.17) 1.81 (1.26-2.59)
Use of dental floss 0.52 (0.32-0.85) 0.25 (0.09-0.68)
Use of mouthwash 0.79 (0.64-0.97) 0.60 (0.44-0.82)
Brushing teeth daily 0.76 (0.58-0.99) 0.74 (0.52-1.07)
Oral hygiene $ 2 min daily 0.84 (0.71-0.99) 0.72 (0.57-0.92)
Change toothbrush every
3 mo or less
0.79 (0.65-0.95) 0.73 (0.56-0.95)
Age of first dental visit
, 30 y
0.95 (0.79-1.15) 1.00 (0.77-1.30)
Last dental visit within 6 mo 0.79 (0.65-0.96) 0.73 (0.55-0.97)
Note: Values are given as adjusted hazard ratio (95% confi-
dence interval). The analyses were stratified by country and
adjusted for age, sex, race (European vs non-European),
smoking history (ever smoker vs nonsmoker), income (above
average vs below average), medical history (diabetes, myocar-
dial infarction), dialysis vintage, and mean arterial blood pres-
sure, serum phosphorus, and hemoglobin values. All
participants with recorded data for all exposure variables
(n5 4,054/4,205) were included in the survival analyses for
edentulousness and the decayed, missing, and filled teeth index
and all dentate participants with complete exposure data
(n5 3,243/3,338) were included in survival analyses for oral
hygiene and dental care practices.
aThe decayed, missing, and filled teeth index is dichotomized
according to World Health Organization criteria as very low to
moderate, ,14, and high, $14.27
Dental Disease and Survival in HemodialysisTo our knowledge, there has never been a compre-
hensive study to assess linkages between dental care
practices with survival in dialysis patients. In a recent
systematic review, existing evidence for associations
between oral health and survival in patients with CKD
was rare and limited to the assessment of mortality
associatedwith periodontitis in the setting of dialysis.10
In 2 small studies involving dialysis patients, peri-
odontitis was associated with increased malnutrition
and systemic inﬂammation,17 and moderate to severe
periodontitis may predict all-cause mortality.18,19
While our ﬁndings are consistent with studies
in the general population showing associations be-
tween tooth loss and oral hygiene with mortality
and cause-speciﬁc death, including cardiovascular
disease and cancer, independent of socioeconomic
disadvantage,7,9,20-22 extrapolation of observational
ﬁndings from the general population to the dialysis
setting is not always appropriate. For example,
higher blood pressure23 and serum cholesterol24
levels are paradoxically associated with better sur-
vival in the setting of advanced kidney disease,
and drugs that reduce cardiovascular events in theAm J Kidney Dis. 2015;66(4):666-676general population, such as statin therapy and anti-
platelet agents, may have smaller or no beneﬁcial
effects for dialysis patients.25,26 Accordingly, the
ﬁndings in this study do not simply conﬁrm data
from other populations, but represent new and test-
able hypotheses for improving outcomes for people
with CKD. To date, these interventions have not
been tested.
Despite growing and consistent evidence within
general and chronic disease populations that dental
health is associated with risks of total and cardio-
vascular death and that oral hygiene and dental care
practices, particularly dental ﬂossing, are associated
with better survival, large trials evaluating the effects
of dental practices and oral hygiene care on patient-
centered outcomes are lacking. This is particularly
striking given the very high population burden of oral
diseases across most global regions.27 A systematic
review based on generally low-quality evidence has
shown that dental health education may have small
positive but poorly sustained effects on plaque accu-
mulation and no impact on caries burden, but bene-
ﬁcial effects on dental knowledge.28 Three trials have
shown that routine scale and polish care in adults may
have little or no effect on gingivitis29 and a trial of
nonsurgical periodontal treatment for periodontitis in
people who had diabetes30 was discontinued prema-
turely because of futility. Notably, no dental trials
have speciﬁcally examined treatment effects on
mortality or cardiovascular end points and none are
available in the CKD population, as suggested might
be appropriate based on the ﬁndings in this study.
The potential beneﬁt of dental health interventions
on survival, cardiovascular events, and quality of life
might be greater in adults with CKD than for other
settings due to the more severe spectrum of oral dis-
ease,31,32 lower use of dental care practices,11 and
substantially poorer survival. Accumulated dental
plaque drives neutrophil-based inﬂammation and
may stimulate cytokine responses within gingival
epithelium.33,34 Additional causal pathways linking
oral bacteria to systematic inﬂammation have been
proposed, including bacteremia secondary to oral
bacteria, circulating oral microbial toxins, and meta-
static immunologic responses to oral microorganisms
(reviewed in35). Accordingly, it is plausible that
dental care and oral hygiene interventions might
modify the measurable systemic inﬂammatory
response and malnutrition that is associated with
dental plaque accumulation and gingivitis,17 which
might contribute directly to accelerated cardiovascular
disease in adults with CKD through nontraditional
mechanisms.36
While the ﬁndings of our study suggest that dental
health and oral hygiene practices represent a
testable risk factor for health in the dialysis setting,673
Figure 3. Multivariable adjusted hazard ratios for cardiovascular mortality for World Health Organization categories of decayed,
missing, and filled teeth index. The maximum number of decayed missing and filled teeth was 32, including the third molars. The
decayed, missing, and filled teeth index is dichotomized according to World Health Organization criteria as very low to
moderate, ,14, and high, $14.27 A larger number of affected teeth indicates more extensive dental disease. Abbreviation: CI, confi-
dence interval.
Palmer et althe observational nature of this study means that it is
hypothesis generating at best. Large pragmatic trials
to evaluate the effects of dental health practices on
survival are required before appropriate policy and
guideline responses can be generated. Based on pre-
vious trial evidence that oral hygiene education had
nonsustained effects on dental health behaviors28 and
that periodontal treatment might be ineffective for
modifying surrogate outcomes in diabetes,30 the ef-
fects of regular funded dental consultation integrated
into care of CKD and end-stage kidney disease on
survival and patient-centered outcomes might be the
most appropriate tested strategy, particularly in-
volving younger patients. Understanding patient ex-
periences and barriers to dental care in this population
might also aid the design of a workable intervention
that aligns with patients’ values to increase patient
acceptability and uptake.37
The limitations of the current study need to be
considered when interpreting the ﬁndings. First, pa-
tients were from various European countries and
Argentina, which may have different causal factors
linking dental exposures to mortality; however,
random-effects analyses were ﬁtted using a shared
frailty model to account for within-country clustering.674Second, although a broad range of social and clinical
factors were able to be accounted for, residual con-
founding in the analyses is still possible. For example,
adjustment for access to dental care or exposure to
ﬂuoridation was not able to be undertaken. Other po-
tential unmeasured confounders include general
receptiveness to health advice, health literacy, and so-
cioeconomic factors. Third, while an association be-
tween age of ﬁrst dental consultation and mortality
outcome was not observed, the question may not have
sufﬁciently assessed whether patients had dental
checkups during childhood, which might have been
most relevant to lifetime risk of tooth loss and therefore
mortality. Finally, assessment was based on a single
dental examination measured after the occurrence of
end-stage kidney disease and therefore could not
inform understanding of the relative contributions of
dental health through childhood and earlier adulthood
to risks of mortality in end-stage kidney disease. The
potential impact of the duration of exposure to dental
disease in the earlier stages of CKDwas hinted at by the
interaction between dental health and age, suggesting
that younger patients who may have experienced more
severe dental pathology earlier in life aremore at risk of
adverse events associated with dental disease.Am J Kidney Dis. 2015;66(4):666-676
Dental Disease and Survival in HemodialysisTooth loss and dental disease were associated with
total and cardiovascular mortality, while oral hygiene
practices and more frequent dental care were associ-
ated with better survival in patients with end-stage
kidney disease treated with hemodialysis. Random-
ized trials of dental interventions in the setting of
CKD are warranted.
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